Car Sales Still Spe...
Health Care: Drugs
Cleveland BioLabs Inc. (CBLI: NASDAQ)
$2.07 0.80 | 62.99%
06/04/12 - 04:00 PM ET
Ratio Comparisons
| Company | Industry | S&P 500 | |
| Valuation Ratios | |||
|---|---|---|---|
| P/E Ratio (TTM) | n.a. | 75.30 | 17.70 |
| P/E High - Last 5 Yrs | n.a. | n.a. | 67.70 |
| P/E Low - Last 5 Yrs | n.a. | n.a. | 12.50 |
| Beta | 1.87 | 0.58 | 0.98 |
| Price to Sales (TTM) | 6.26 | 4.62 | 1.42 |
| Price to Book (MRQ) | 9.16 | 3.44 | 2.41 |
| Price to Tangible Book (MRQ) | 9.16 | 6.74 | 5.08 |
| Price to Cash Flow (TTM) | -13.50 | 26.10 | 9.80 |
| Price to Free Cash Flow (TTM) | -2.30 | 48.80 | 17.40 |
| Dividends | |||
| Dividend Yield (%) | 0.00 | 0.50 | 2.10 |
| Dividend Yield - 5 Yr Avg (%) | n.a. | 0.20 | 2.20 |
| Dividend 5 Yr Growth Rate (%) | n.a. | n.a. | -0.76 |
| Payout Ratio (TTM) | 0.00 | 3.00 | 30.00 |
| Sales (MRQ) vs Qtr 1 Yr Ago (%) | -62.40 | 9.90 | 11.80 |
| Sales (TTM) vs TTM 1 Yr Ago (%) | -42.70 | 7.70 | 9.20 |
| Growth Rates (%) | |||
| Sales - 5 Yr Growth Rate (%) | 48.94 | 9.03 | 1.79 |
| EPS (MRQ) vs Qtr 1 Yr Ago (%) | n.a. | 18.50 | 17.50 |
| EPS (TTM) vs TTM 1 Yr Ago (%) | n.a. | 18.50 | 17.50 |
| EPS - 5 Yr Growth Rate (%) | n.a. | n.a. | -1.66 |
| Capital Spending - 5 Yr Growth Rate (%) | 9.02 | -4.13 | -1.17 |
| Financial Strength | |||
| Quick Ratio (MRQ) | 2.70 | 2.90 | 1.10 |
| Current Ratio (MRQ) | 2.80 | 3.50 | 1.60 |
| LT Debt to Equity (MRQ) | 0.03 | 0.41 | 0.82 |
| Total Debt to Equity (MRQ) | 0.04 | 0.45 | 0.96 |
| Interest Coverage (TTM) | n.a. | 6.20 | 5.50 |
| Profitability Ratios (%) | |||
| Gross Margin (TTM) | n.a. | 84.10 | 46.90 |
| Gross Margin - 5 Yr Avg | n.a. | 83.50 | 47.70 |
| EBITD Margin (TTM) | n.a. | 27.30 | 18.90 |
| EBITD - 5 Yr Avg | -190.74 | 0.00 | 0.00 |
| Pre-Tax Margin (TTM) | -81.20 | 14.10 | 12.10 |
| Pre-Tax Margin - 5 Yr Avg | n.a. | 10.60 | 10.30 |
| Management Effectiveness (%) | |||
| Net Profit Margin (TTM) | -0.54 | 0.10 | 0.09 |
| Net Profit Margin - 5 Yr Avg | n.a. | 5.30 | 7.00 |
| Return on Assets (TTM) | -14.70 | 4.70 | 3.10 |
| Return on Assets - 5 Yr Avg | -104.00 | 2.20 | 2.50 |
| Return on Investment (TTM) | -76.00 | 6.10 | 7.90 |
| Return on Investment - 5 Yr Avg | -6,507.00 | 2.80 | 6.50 |
| Efficiency | |||
| Revenue/Employee (TTM) | 124,959.00 | 701,747.00 | 449,376.00 |
| Net Income/Employee (TTM) | -67,272.00 | 83,589.00 | 39,003.00 |
| Receivable Turnover (TTM) | 4.70 | 5.80 | 7.60 |
| Inventory Turnover (TTM) | n.a. | 1.30 | 8.30 |
| Asset Turnover (TTM) | 0.30 | 0.40 | 0.40 |
Portfolios with CBLI
- Portfolio NameUser Type
- Contributor5 Health Care Stocks With U...
- Contributor10 Surging Stocks Most at R...
- UserNEW HOME savings
- UserDan128
- UserJustchattin Portfolio 1
- UserSPQR
- UserPICKIN
- UserTom's picks
- Userboo boo
- UserSrRock33's
Latest CBLI Headlines from TheStreet
- More Biotech Twitter Mailbag: Orexigen, Affymax, YM Bio, Spectrum & More 02.29.12 | 07:02 am
- Cleveland BioLabs Stock Gaps Down On Today's Open (CBLI) 06.17.11 | 11:06 am
- Cleveland BioLabs Stock Gaps Down On Today's Open (CBLI) 05.31.11 | 09:05 am
- Biotech Stock Mailbag: Bio-Hazards 03.25.11 | 07:03 am
- 5 Health Care Stocks With Upside 03.21.11 | 11:03 am
- Surging Stocks Most at Risk of a Decline 10.28.10 | 07:10 am
- Stock Offerings: Digital Realty Trust 06.03.10 | 10:06 am
- Sunesis, Taser: Midday Volume Plays 01.06.10 | 11:01 am
- PharmAthene, ICX Technologies: Midday Volume Plays 12.30.09 | 02:12 pm
- Cleveland BioLabs Loses Out On Defense Contract 01.04.08 | 09:01 pm
Press Releases for CBLI
- Mintz Levin Represents Cleveland Biolabs, Inc. In $8.4 Million Direct Offering - Business Wire 01.04.11 | 09:01 am
Partner Headlines for CBLI
- Morning Market Movers - Benzinga 06.04.12 | 09:06 am
- Ultimate Market Recap: Medtox Makes Good, BofA Holds Out on Shareholders - Wall St. Cheat Sheet 06.04.12 | 07:06 am
- 3 Stocks Illuminating Green on a Red Trading Day - Wall St. Cheat Sheet 06.04.12 | 02:06 am
- Will the Next Apple or Google Be Found Among These Micro Caps? - Seeking Alpha 08.18.11 | 09:08 am
- Rodman & Renshaw Lower Cleveland BioLabs PT to $8 - Benzinga 06.27.11 | 04:06 pm
- Zacks #5 Rank Additions for Monday - Tale of the Tape - Zacks 06.20.11 | 09:06 am
- Future Biotech Superstars - Seeking Alpha 03.30.11 | 09:03 am
- Company News for March 16, 2011 - Corporate Summary - Zacks 03.16.11 | 10:03 am
- Morning Market Movers (SSFN, BWEN, ZNWAW, CBLI) - Benzinga 03.15.11 | 09:03 am
- Friday Options Recap - Seeking Alpha 03.11.11 | 04:03 pm
